These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7698176)

  • 1. Competitive NMDA receptor antagonists attenuate the behavioural and neurochemical effects of amphetamine in mice.
    Bristow LJ; Thorn L; Tricklebank MD; Hutson PH
    Eur J Pharmacol; 1994 Nov; 264(3):353-9. PubMed ID: 7698176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine.
    Hutson PH; Bristow LJ; Thorn L; Tricklebank MD
    Br J Pharmacol; 1991 Aug; 103(4):2037-44. PubMed ID: 1655150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons.
    French ED
    Eur J Pharmacol; 1992 Jun; 217(1):1-7. PubMed ID: 1397021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice.
    Furuya Y; Kagaya T; Ogura H; Nishizawa Y
    Eur J Pharmacol; 1999 Jan; 364(2-3):133-40. PubMed ID: 9932715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
    Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
    Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755.
    Waters N; Lundgren C; Hansson LO; Carlsson ML
    J Neural Transm (Vienna); 1996; 103(1-2):117-29. PubMed ID: 9026366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
    Benveniste M; Mayer ML
    Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks.
    Parada-Turska J; Turski WA
    Neuropharmacology; 1990 Dec; 29(12):1111-6. PubMed ID: 2149871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine.
    French ED; Ferkany J; Abreu M; Levenson S
    Neuropharmacology; 1991 Oct; 30(10):1039-46. PubMed ID: 1836840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats.
    Bristow LJ; Hogg JE; Hutson PH
    Neuropharmacology; 1997 Feb; 36(2):241-50. PubMed ID: 9144662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperactivity induced by N-methyl-d-aspartate injections into nucleus accumbens: lack of evidence for mediation by dopaminergic neurons.
    O'Neill KA; Carelli RM; Jarvis MF; Liebman JM
    Pharmacol Biochem Behav; 1989 Dec; 34(4):739-45. PubMed ID: 2560212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive and uncompetitive N-methyl-D-aspartate antagonist discriminations in pigeons: CGS 19755 and phencyclidine.
    Baron SP; Woods JH
    Psychopharmacology (Berl); 1995 Mar; 118(1):42-51. PubMed ID: 7597121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism by CPP (+/-)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, of beta-phenylethylamine (PEA)-induced hypermotility in mice of different strains.
    Lapin IP
    Pharmacol Biochem Behav; 1996 Oct; 55(2):175-8. PubMed ID: 8951951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of pretreatment with competitive or noncompetitive NMDA antagonists on vestibular compensation.
    Sansom AJ; Darlington CL; Smith PF
    Pharmacol Biochem Behav; 1993 Dec; 46(4):807-11. PubMed ID: 8309959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: roles of multiple monoaminergic receptors in relation to the actions of antipsychotic agents.
    Millan MJ; Gobert A; Bervoets K; Rivet JM; Veiga S; Brocco M
    J Pharmacol Exp Ther; 2000 Feb; 292(2):672-83. PubMed ID: 10640305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist.
    Fuller RW; Hemrick-Luecke SK; Ornstein PL
    Neuropharmacology; 1992 Oct; 31(10):1027-32. PubMed ID: 1436384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
    Ouagazzal A; Nieoullon A; Amalric M
    Eur J Pharmacol; 1994 Jan; 251(2-3):229-36. PubMed ID: 8149978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of and interactions between antagonists for different sites on the NMDA receptor complex on hippocampal and striatal acetylcholine efflux in vivo.
    Hutson PH; Hogg JE
    Eur J Pharmacol; 1996 Jan; 295(1):45-52. PubMed ID: 8925873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex.
    Tricklebank MD; Bristow LJ; Hutson PH; Leeson PD; Rowley M; Saywell K; Singh L; Tattersall FD; Thorn L; Williams BJ
    Br J Pharmacol; 1994 Nov; 113(3):729-36. PubMed ID: 7858861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.